EC Number   |
Inhibitors |
Structure  |
|---|
    6.3.1.9 | more |
the enzyme mediates resistance to H2O2 and organic hyperoxids, and to trypanocidic drugs |
 |
| 6.3.1.9 | more |
limited proteolysis with trypsin or factor Xa result in cleavage of wild-type and mutant enzymes at R553 followed by loss of activity, cleavage of wild-type and mutant R553Q can be delayed by presence of substrates |
|
| 6.3.1.9 | more |
synthesis and inhibitory potencies of indazole analogue inhibitors, overview |
|
| 6.3.1.9 | more |
screening of different scaffold-derived compounds for inhibitory activity on enzyme TryS, overview. No inhibition by [3-[4-([6-(3,4-dimethoxyphenyl)-7-[(ethylcarbamothioyl)amino]pyrido[2,3-d]pyrimidin-2-yl]amino)phenyl]propyl]molybdenum(1+) and 1,4,7-trioxo-1lambda5,4lambda5,7lambda5-benzo[1,2-c:3,4-c':5,6-c'']tris[1,2,5]oxadiazole |
|
| 6.3.1.9 | more |
screening of different scaffold-derived compounds for inhibitory activity on enzyme TryS, overview. No effect by 8-[(2E)-2-[(2,4-dihydroxyphenyl)methylidene]hydrazinyl]-7-(2-hydroxy-3-phenoxypropyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione and J31 |
|
| 6.3.1.9 | more |
screening of different scaffold-derived compounds for inhibitory activity on enzyme TryS, overview |
|
| 6.3.1.9 | glutathione |
substrate inhibition |
  |
| 6.3.1.9 | KCl |
approx. 50% inhibition at 500 mM |
|
| 6.3.1.9 | GSH |
substrate inhibition |
|
| 6.3.1.9 | ammonium sulfate |
almost complete inhibition at 500 mM |
|
